Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gilead Sciences
(NQ:
GILD
)
77.73
+0.72 (+0.93%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gilead Sciences
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
48
49
Next >
MacroGenics Shares Jump On Gilead Licensing Pact For Blood Cancer Candidates
October 17, 2022
Via
Benzinga
Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies
October 17, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off
October 16, 2022
All three of these medical stocks offer a high-yield dividend.
Via
The Motley Fool
Why Cash-Rich Companies And #ETFs Are Beating The Market?
October 15, 2022
Investors believe that “cash is king” in the current environment of surging inflation, rising rates, and a potential economic downturn. ETFs that hold cash-rich companies have seen a lot of interest...
Via
Talk Markets
Gilead Sciences to Release Third Quarter 2022 Financial Results on Thursday, October 27, 2022
October 13, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead's Trodelvy Under FDA Review For Pre-Treated HR+/HER2- Metastatic Breast Cancer
October 11, 2022
Via
Benzinga
Halliburton To Jump Around 44%? This Analyst Slashes PT On Block By 26%
October 13, 2022
Morgan Stanley boosted the price target on Halliburton Company (NYSE: HAL) from $40 to $42. Halliburton shares rose 0.8% to close at $29.80 on Wednesday.
Via
Benzinga
Dividend Income Update September 2022
October 13, 2022
With the start of the final quarter of 2022, it’s time to take a look back at my previous month of dividend income.
Via
Talk Markets
Gilead Sciences Whale Trades Spotted
October 12, 2022
Someone with a lot of money to spend has taken a bearish stance on Gilead Sciences (NASDAQ:GILD). And retail traders should know. We noticed this today when the big position showed up on publicly...
Via
Benzinga
These 2 Growth Stocks Have Potential Catalysts on the Way
October 12, 2022
Both drugmakers have been outperforming the market -- which may continue if they earn important regulatory approvals soon.
Via
The Motley Fool
Want to Collect 4% in Dividends Every Month? Buy These 3 Stocks
October 12, 2022
These stocks pay at different intervals and collectively can ensure you're collecting a dividend payment each month.
Via
The Motley Fool
Expert Ratings for Gilead Sciences
October 04, 2022
Gilead Sciences (NASDAQ:GILD) has observed the following analyst ratings within the last quarter:
Via
Benzinga
4 Biotech Stocks With Huge Incoming Catalysts
October 12, 2022
All four of these drugmakers are expecting important FDA approval decisions over the next few months.
Via
The Motley Fool
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Gilead’s Trodelvy® for Pre-Treated HR+/HER2- Metastatic Breast Cancer
October 11, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
How to Find Stocks That Rise 10x
October 10, 2022
Investors looking for 10X stocks should prioritize companies in high-growth areas that demonstrate high earnings quality.
Via
InvestorPlace
Global Cervical Cancer Treatment Market Size Expected to Reach $11 Billion By 2027
October 06, 2022
Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing...
Via
FinancialNewsMedia
If You Invested $100 In This Stock 20 Years Ago, You Would Have $1,500 Today
October 05, 2022
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 20 years by 6.67% on an annualized basis producing an average annual return of 14.39%. Currently, Gilead Sciences has a market...
Via
Benzinga
A Bullish Sign Appears On Gilead Sciences's Chart
October 05, 2022
If history is any guide, there may be good fortune ahead for shares of Gilead Sciences (NASDAQ:GILD). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for...
Via
Benzinga
What Are Whales Doing With Gilead Sciences
October 04, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Gilead Sciences. Looking at options history for Gilead Sciences (NASDAQ:GILD) we detected 17 strange trades.
Via
Benzinga
Why This Gilead Analyst Believes The Stock Is Highly Undervalued
October 04, 2022
While there is increased visibility for Gilead Sciences, Inc’s (NASDAQ: GILD) HIV franchise, its emerging oncology franchise is not well reflected in its valuation, according to JPMorgan.
Via
Benzinga
Large Cap Biopharmaceuticals: Core Holdings For Your Portfolio
October 03, 2022
Now that some clarity is apparent for drug pricing legislation you should have a few large-cap biopharmaceutical stocks in your portfolio.
Via
Talk Markets
Kite Receives U.S. FDA Approval of Viral Vector Manufacturing Facility in Southern California to Produce Commercial Product
October 03, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
3 Biotech Stocks to Sell in October
September 29, 2022
These biotech stocks to sell are at a cross roads with their businesses with few growth catalysts ahead amid this turbulent market.
Via
InvestorPlace
Vietnam Law May Impact Facebook, Twitter; Amazon Has A Sleep Tracker; India Lures Apple, Dell, HP: Top Financial Media Stories Thursday, Sept. 29
September 29, 2022
Reuters
Via
Benzinga
Gilead's Investigation Reveals Two Kingpins Directly Associated With Fake HIV Medications Scheme
September 29, 2022
U.S. District Judge Ann Donnelly has ordered to freeze several assets related to people and entities accused of operating a U.S. supply chain that distributes counterfeit bottles of Gilead Sciences...
Via
Benzinga
7 Monthly Dividend Stocks to Buy for Safety
September 29, 2022
These safe monthly dividend stocks offer investors incredible dividend yields and healthy upside potential
Via
InvestorPlace
The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market
September 27, 2022
Despite the ongoing worries on Wall Street, these are the best stocks to buy to play the hidden bull market.
Via
InvestorPlace
Gilead Joins First-of-its-Kind Public-Private Initiative to Improve Management of Viral Hepatitis in Vietnam and the Philippines
September 22, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead Sciences Completes Acquisition of MiroBio
September 20, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
Here's How Much $100 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today
September 20, 2022
Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 15 years by 1.63% on an annualized basis producing an average annual return of 7.98%. Currently, Gilead Sciences has a market...
Via
Benzinga
< Previous
1
2
...
23
24
25
26
27
28
29
30
31
...
48
49
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.